Skip to main content
    M

    Medtronic PLC (MDT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $102.90
    +0.04 (+0.04%)

    Market Cap: $131.57B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Medtronic PLC (MDT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Medtronic (MDT) to earn $5.98 per share in the fiscal year ending Apr 30, 2027, on revenue of $38.97B. Of 30 analysts, 20 rate the stock Buy or Strong Buy, 10 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Apr 30, 2027 were revised up and 2 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 30 ratings average 2.23, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.

    RatingAnalystsShare
    Strong Buy310.0%
    Buy1756.7%
    Hold1033.3%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    30

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 7.2% and revenue estimates rise 3.7%.

    Fiscal year ending Apr 30, 2027
    $5.98
    EPS consensus, revenue $38.97B
    Fiscal year ending Apr 30, 2028
    $6.41
    EPS consensus, revenue $40.40B
    Next report
    Nov 24, 2026
    Confirmed, before the open

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Apr 30, 2027$5.98$5.93 to $6.0230$38.97B$37.51B to $39.19B28
    Apr 30, 2028$6.41$6.24 to $6.6330$40.40B$36.87B to $41.70B28

    Quarterly Estimates

    The EPS consensus rises from $1.42 for the quarter ending Jan 31, 2027 to $1.79 for the quarter ending Apr 30, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jan 31, 2027$1.42$1.40 to $1.4824$9.52B$9.46B to $9.70B23
    Apr 30, 2027$1.79$1.67 to $1.9026$10.40B$10.02B to $10.88B25

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 6 upward and 5 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Apr 30, 202722
    Fiscal year ending Apr 30, 202841
    Quarter ending Jan 31, 202702

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Apr 30, 2027 has risen 0.5% from $5.95.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Apr 30, 2027$5.98$5.98$5.98$5.97$5.95+0.4%
    Fiscal year ending Apr 30, 2028$6.41$6.41$6.41$6.40$6.41-0.1%
    Quarter ending Jan 31, 2027$1.42$1.42$1.42$1.42$1.43-0.5%

    Frequently Asked Questions About MDT

    What is the MDT stock forecast?

    Consensus analyst estimates put Medtronic's EPS at $5.98 for the fiscal year ending Apr 30, 2027, on revenue of $38.97B. The consensus rating from 30 analysts is Buy.

    How do analysts rate MDT stock?

    Of 30 analysts covering Medtronic, 3 rate it Strong Buy, 17 Buy, 10 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from MDT next year?

    For the fiscal year ending Apr 30, 2027, the consensus EPS estimate is $5.98, with estimates from $5.93 to $6.02 from 30 analysts. For the fiscal year ending Apr 30, 2028, the consensus EPS estimate is $6.41, with estimates from $6.24 to $6.63 from 30 analysts.

    What revenue do analysts expect from Medtronic next year?

    For the fiscal year ending Apr 30, 2027, the consensus revenue estimate is $38.97B, with estimates from $37.51B to $39.19B. For the fiscal year ending Apr 30, 2028, the consensus revenue estimate is $40.40B, with estimates from $36.87B to $41.70B.

    How many analysts cover MDT?

    30 analysts rate Medtronic stock, and 30 analysts estimate its EPS for the fiscal year ending Apr 30, 2027.